Anzeige
Meldung des Tages: +52% am Freitag und das könnte erst der Anfang sein: Zefiro sichert sich millionenschwere Staatsaufträge

Viatris News

Aktie
WKN:  A2QAME ISIN:  US92556V1061 US-Symbol:  VTRS Branche:  Pharmazeutika Land:  USA
12,268 €
-0,202 €
-1,62%
08:30:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
12,24 Mrd. €
Streubesitz
12,81%
KGV
-23,49
Dividende
0,42 EUR
Dividendenrendite
4,04%
Nachhaltigkeits-Score
42 %
Index-Zuordnung
S&P 500

Viatris News

15.10.25 - PR Newswire
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-​Pacific Region PR ...
13.10.25 - PR Newswire
Viatris to Participate in Upcoming Investor Conferences
Viatris to Participate in Upcoming Investor Conferences PR Newswire
08.10.25 - PR Newswire
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row PR Newswire
01.10.25 - PR Newswire
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025 PR Newswire
30.08.25 wallstreetONLINE Redaktion
Börsen-Nieten im Fokus: Diese 10 S&P-500-Aktien haben ein Jahrzehnt lang nur enttäuscht – bis jetzt!
Langfristige Verluste sind im S&P 500 eine Seltenheit – doch zehn Aktien haben in den vergangenen zehn Jahren klar enttäuscht. Welche dieser Nachzügler jetzt mit starken ...
19.08.25 - PR Newswire
Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer PR Newswire
11.08.25 - PR Newswire
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S. PR Newswire
07.08.25 - PR Newswire
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance PR Newswire
05.08.25 - PR Newswire
Viatris Announces Quarterly Dividend
Viatris Announces Quarterly Dividend PR Newswire
05.08.25 - PR Newswire
Viatris Announces Appointment of David Simmons to the Company's Board of Directors
Viatris Announces Appointment of David Simmons to the Company's Board of Directors PR Newswire
01.08.25 - PR Newswire
Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference
Viatris Announces Five Data Presentations on Novel Fast-​Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference PR Newswire
18.07.25 - PR Newswire
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis PR Newswire
26.06.25 - PR Newswire
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia PR Newswire
12.06.25 - PR Newswire
Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025
Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 PR Newswire
03.06.25 - Newsfile
VTRS DEADLINE TODAY: Viatris Inc. Shareholders are Reminded of Today's June 3 Securities Class Action Deadline
New York, New York--(Newsfile Corp. - June 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ ...
02.06.25 - Newsfile
VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - VTRS
New York, New York--(Newsfile Corp. - June 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) ...
02.06.25 - PR Newswire
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
02.06.25 - PR Newswire
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
02.06.25 - PR Newswire
DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025
DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 PR Newswire
02.06.25 - PR Newswire
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-​Contrast Conditions ...

Newssuche

Videos

newspaper
19.04.26
CRASH-​ALARM?! Steht die nächste Baisse unmittelbar bevor?
Mehr »